Rappel Ou Alerte De Sécurité sur "Reactor Buckets of Architect Analyzers", Order No. 7C15-01, manufactured by Abbott GmbH, Germany

Selon Agencia Española de Medicamentos y Productos Sanitarios (Via FOI), ce/cet/cette rappel ou alerte de sécurité concerne un dispositif en/au/aux/à Spain qui a été fabriqué par Abbott GmbH.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Recall / Safety Alert
  • Date
    2013-01-03
  • Pays de l'événement
  • Source de l'événement
    AEMPSVFOI
  • Notes / Alertes
    The data from Spain is current through June 2018. All of the data comes from Agencia Española de Medicamentos y Productos Sanitarios, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Spain.
  • Notes supplémentaires dans les données
  • Action
    Withdrawal of certain batches from the "Architect Analyzer Reaction Buckets", reference no. 7C15-01, because interaction with any batch of the "Architect 25-OH Vitamin D" test, reference number 3L52 may occur

Manufacturer

  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    AEMPSVFOI